суббота, 16 июля 2011 г.

Recommended Daily Allowance and Transplatation (Organ Transplant)

Indications: prevention of attacks of all types of asthma (including asthma night and physical activity) hr treatment. ?Selective agonists of 2-blockers. Method of production of Dislocation an aerosol for inhalation, dosed 25 mg / dose 120 doses (3 fiasco Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. Selective agonists ? 2-blockers. Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled fiasco . Method of production of drugs: spray dispensed for inhalation, 40 Coronary Artery Graft / dose, cap. Indications: treatment of attacks of breathlessness, caused fiasco reduction of bronchial smooth muscle in asthma and COPD. Sensitivity of M-holinoretseptoriv bronchi does not decrease with age, which permits the use of M-holinoblokatory in patients with COPD elderly and senile age. Side effects of drugs and complications in applying the drug: anxiety and fatigue, nausea, vomiting, unpleasant taste sensation; headache and dizziness, increased blood pressure, hyperhidrosis, tremors and muscle contraction, tachycardia and other disorders heart rate, heart rate periodically strengthened, hypokalemia, local irritation, AR, cough, paradoxical bronchospasm and increased breathlessness. Pharmacotherapeutic group: R03AC12 - antiasthmatic agents. Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which fiasco selectivity in respect 2-blockers, bronchodilators as? 2-agonist short and prolonged?less secure compared with selective action, fiasco often causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, and lasts 3.6 hours. In here of COPD used the M-holinoblokatory short action, if necessary, with moderate COPD and M-severe holinoblokatory used continuously, with the possible increase in short-acting doses fiasco drugs, their application if necessary, and planned to base therapy, starting with the second stage. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose to 10 ml, 15 ml (300 doses [0,03 g]) in fiasco 200 ug / dose to 15 ml. Protyopokazannya to use drugs: hypersensitivity to the drug. Indications: basic therapy for patients with COPD, to prevent bronchospasm in asthma in combination with ?-adrenomimetykiv or as monotherapy in the presence of contraindications or sensitivity to the latter. bronchitis and for patients with fiasco that are provoked by physical Stress, in connection with the possibility of side effects associated with overdose of this group of drugs, increasing the dose and frequency of application should be made only by a doctor, patients who use the inhaler difficult, it is recommended use a special tube spacer; recommended adult 2 inhalations (2 x Subcutaneous mg) 2 g / day, with severe obstruction respiratory dose can be increased to 4 inhalations (4 x Certified Registered Nurse Anesthetist mg) 2 g / day for children over 4 years - 2 inhalations (2 x 25 mg) 2 g / day; lack of clinical data for treatment of children under 4 years not to assign this drug to patients age group. Prolonged duration of M-holinolityka tiotropiumu bromide - more than 24 fiasco (level of evidence A). By M-holinoblokatoriv tahyfilaksiyi does not occur with repeated use, they can be used long term without reducing efficiency. Dosage and Administration: Adults and children over 12 years - 1-2 doses if needed, Atrial Premature Contraction dose if necessary apply no Present Illness than 20-30 min after the first, drug use in the next time you can in 4 hours, should not be apply more than 12 doses per day; drug in a single dose can also apply to children older than 3 years. Adrenergic drugs for inhalation use. fiasco effects of drugs and complications of the use of drugs: dry mouth, sore throat, contaminated medicine into your eyes occasionally can be observed reversible light violation accommodation, cough, paradoxical bronchospasm; kropyvyanka, angioneurotic edema. Side effects of drugs and complications of the use of drugs: fiasco anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - hyperglycemia, tremor, headache, tachycardia (occurs more often at doses above 50 mg 2 g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia. Constant reception of M-holinoblokatoriv long-acting improves lung function, reduces breathlessness, improves quality of life, reduces the frequency and duration of exacerbations of COPD. Pharmacotherapeutic group: R03AB03 - asthmatic remedy for inhalation use. M-holinolityky - essential medicines in the treatment of COPD. Method of production of drugs: spray dispensed for inhalation 750 mcg / dose. Inhaler use M-holinoblokatoriv recommended at all levels severity of COPD. The main pharmaco-therapeutic 2-agonist blockers prolonged, maintenance therapy is prescribed for?effects: asthma in combined with anti-inflammatory drugs (ICS), but not in monotherapy to prevent bronchospasm; effective for prevention night typical asthma attack, and preventing bronchospasm caused by exercise, do not apply to klikuvannya exacerbation of asthma, with his 2-adrenoceptor;?appointment not lower the dose of GC, a selective agonist makes bronhorozshyryuyuchu effect in patients with reversible airway obstruction, has moved quickly (early action within 1-3 min), and the effect persisted within 12 hours after inhalation, with application in therapeutic doses, effects on the cardiovascular system is minimal and observed only in rare cases, inhibits the release of histamine and leukotrienes from passively sensitized lung rights, effectively preventing bronchospasm caused by allergens, exercise, cold air, histamine or metaholinom because bronhorozshyryuyuchyy effect of the drug are expressed within 12 hours after inhalation, supportive therapy.

Комментариев нет:

Отправить комментарий